CLABSI vs CRBSI: Key Differences
CLABSI (Central Line-Associated Bloodstream Infection) is a surveillance definition used for infection control tracking, while CRBSI (Catheter-Related Bloodstream Infection) is a clinical diagnostic definition that requires specific laboratory evidence proving the catheter is the actual source of infection. 1
Defining CRBSI (Clinical Diagnosis)
CRBSI requires definitive laboratory proof that the catheter is the infection source 1:
- Same organism must grow from both:
- At least 1 percutaneous blood culture AND
- Culture of the catheter tip (≥15 CFU by semiquantitative or ≥100 CFU by quantitative method)
OR paired blood cultures (catheter hub + peripheral vein) meeting one of these criteria:
- Quantitative cultures: ≥3-fold higher colony count from catheter vs. peripheral blood
- Differential time to positivity (DTP): Catheter blood culture turns positive ≥2 hours before peripheral culture
The patient must have clinical manifestations (fever, chills, hypotension) with no other apparent infection source 1.
Defining CLABSI (Surveillance Definition)
CLABSI is a simpler, broader definition designed for surveillance purposes 1:
- Patient has a central line in place (or removed within 48 hours)
- Positive blood culture(s)
- Clinical signs of infection
- No requirement to prove the catheter is the source
- Does not require catheter tip cultures or differential blood culture techniques
Critical caveat: The CLABSI definition explicitly states it "differs from the definition of catheter-related bloodstream infection used for infection-control surveillance activities" 1.
Why This Distinction Matters Clinically
CLABSI significantly overestimates true catheter-related infections 2, 3, 4:
- Only 48.4% of CLABSI cases met CRBSI criteria when rigorously evaluated 2
- In cancer patients, only 47% of CLABSI cases were confirmed as CRBSI 3
- CLABSI shows poor agreement with CRBSI at the individual patient level (pR² = 0.34) and poor capture at the study level (R² = 0.28) 4
The problem: CLABSI cannot exclude other infection sources (pneumonia, urinary tract infection, intra-abdominal infections, mucosal barrier injury in immunocompromised patients). It simply identifies bloodstream infections that occur when a central line is present 2, 3.
Practical Clinical Algorithm
For clinical decision-making (deciding whether to remove a catheter or treat for catheter infection):
- Use CRBSI criteria - requires laboratory confirmation
- Obtain paired blood cultures (catheter + peripheral) before antibiotics
- Consider catheter tip culture if removing the line
- Apply quantitative or DTP methods when available 1
For surveillance and quality metrics (hospital reporting, benchmarking):
- Use CLABSI definition - simpler, no special laboratory techniques required
- Recognize this will capture some non-catheter-related infections
- Accept that approximately 50% may not be true CRBSI 2, 3
Common Pitfalls
Avoid these errors:
- Don't assume every CLABSI means the catheter caused the infection - it may be coincidental 2, 4
- Don't use CLABSI rates for clinical effectiveness research - they don't reliably reflect treatment effects on true catheter infections 4
- Don't remove catheters based solely on CLABSI criteria without considering alternative infection sources 3
- Be especially cautious in cancer patients with mucosal barrier injury, where CLABSI dramatically overestimates CRBSI (only 18% confirmed as CRBSI) 3
Financial implications: Hospitals face penalties for CLABSI despite potential misclassification of infections that aren't truly catheter-related 5.